Latent tuberculosis infection: What we know about its genetic control?

Tuberculosis

Volumn 94, Issue 5, 2014, Pages 462-468

  Kondratieva, Tatiana ^a   Azhikina, Tatyana ^b   Nikonenko, Boris ^a   Kaprelyants, Arseny ^c   Apt, Alexander ^a  

^a CENTRAL TUBERCULOSIS RESEARCH INSTITUTE   (Russian Federation)

^b SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

^c Institute of Biochemistry   (Russian Federation)

Author keywords

Animal models; Gene expression; Host genetics; Latent tuberculosis; Short RNA; Treatment

Indexed keywords

ALPHA CRYSTALLIN; BACTERIAL TOXIN; MAZF TOXIN; SIGMA FACTOR; TRANSCRIPTION FACTOR LUXR; TRANSCRIPTION FACTOR RELA; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG; UNTRANSLATED RNA;

BACTERIAL GENE; BACTERIAL GENETICS; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM CULTURE; DNA MICROARRAY; DOSR REGULON; DOWN REGULATION; DRUG EFFICACY; GENE EXPRESSION; GENETIC REGULATION; GENETIC VARIABILITY; GENOMIC INSTABILITY; HOST; HSPX GENE; HUMAN; IMMUNE RESPONSE; LATENT TUBERCULOSIS; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; ORGAN CULTURE; PHENOTYPE; POSTPRIMARY TUBERCULOSIS; REGULON; REVIEW; RPF GENE; TRANSCRIPTION FACTOR LUXR GENE; TRANSCRIPTION FACTOR RELA GENE; TUBERCULOSIS DORMANCY; UPREGULATION; WILD TYPE; ANIMAL; DISEASE MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PATHOGENICITY; TREATMENT OUTCOME; VIRULENCE;

ANIMALS; ANTITUBERCULAR AGENTS; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HOST-PATHOGEN INTERACTIONS; HUMANS; LATENT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; PHENOTYPE; RNA, UNTRANSLATED; TREATMENT OUTCOME; VIRULENCE;

EID: 84908137624     PISSN: 14729792     EISSN: 1873281X     Source Type: Journal    
DOI: 10.1016/j.tube.2014.06.009     Document Type: Review

References (95)

1. C.E. Barry 3rd, H.I. Boshoff, V. Dartois, T. Dick, S. Ehrt, J. Flynn, D. Schnappinger, R.J. Wilkinson, and D. Young The spectrum of latent tuberculosis: rethinking the biology and intervention strategies Nat Rev Microbiol 7 2009 845 855
2. A. Cobat, C.J. Gallant, L. Simkin, G.F. Black, K. Stanley, J. Hughes, T.M. Doherty, W.A. Hanekom, B. Eley, J.P. Jaïs, A. Boland-Auge, P. van Helden, J.L. Casanova, L. Abel, E.G. Hoal, E. Schurr, and A. Alcaïs Two loci control tuberculin skin test reactivity in an area hyperendemic for tuberculosis J Exp Med 206 2009 2583 2591
3. T. Lillebaek, A.B. Andersen, A. Dirksen, E. Smith, L.T. Skovgaard, and A. Kok-Jensen Persistent high incidence of tuberculosis in immigrants in a low-incidence country Emerg Infect Dis 8 2002 679 684
4. S.H. Kaufmann Future vaccination strategies against tuberculosis: thinking outside the box Immunity 33 2010 567 577
5. T.H. Ottenhoff, and S.H. Kaufmann Vaccines against tuberculosis: where are we and where do we need to go? PLoS Pathog 8 2012 e1002607
6. P.R. Gangadharam Mycobacterial dormancy Tuber Lung Dis 76 1995 477 479
7. S. Ahmad Pathogenesis, immunology, and diagnosis of latent Mycobacterium tuberculosis infection Clin Dev Immunol 2011 2011 814943
8. P.J. Cardona A dynamic reinfection hypothesis of latent tuberculosis infection Infection 37 2009 80 86
9. T. Ulrichs, and S.H. Kaufmann New insights into the function of granulomas in human tuberculosis J Pathol 208 2006 261 269
10. M.C. Chao, and E.J. Rubin Letting sleeping dos lie: does dormancy play a role in tuberculosis? Annu Rev Microbiol 64 2010 293 311
11. J. Dworkin, and I.M. Shah Exit from dormancy in microbial organisms Nat Rev Microbiol 8 2010 890 896
12. M. Gengenbacher, and S.H. Kaufmann Mycobacterium tuberculosis: success through dormancy FEMS Microbiol Rev 36 2012 514 532
13. S. Ehlers Lazy, dynamic or minimally recrudescent? on the elusive nature and location of the mycobacterium responsible for latent tuberculosis Infection 37 2009 87 95
14. E.J. Munoz-Elias, J. Timm, T. Botha, W.T. Chan, J.E. Gomez, and J.D. McKinney Replication dynamics of Mycobacterium tuberculosis in chronically infected mice Infect Immun 73 2005 546 551
15. Z. Yang, M. Rosenthal, N.A. Rosenberg, S. Talarico, L. Zhang, C. Marrs, V.∅. Thomsen, T. Lillebaek, and A.B. Andersen How dormant is Mycobacterium tuberculosis during latency? A study integrating genomics and molecular epidemiology Infect Genet Evol 11 2011 1164 1167
16. H.D. Park, K.M. Guinn, M.I. Harrell, R. Liao, M.I. Voskuil, M. Tompa, G.K. Schoolnik, and D.R. Sherman Rv3133c/dosR is a transcription factor that mediates the hypoxic response of Mycobacterium tuberculosis Mol Microbiol 48 2003 833 843
17. D.R. Sherman, M. Voskuil, D. Schnappinger, R. Liao, M.I. Harrell, and G.K. Schoolnik Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding alpha -crystallin Proc Natl Acad Sci USA 98 2001 7534 7539
18. M.I. Voskuil, D. Schnappinger, K.C. Visconti, M.I. Harrell, G.M. Dolganov, D.R. Sherman, and G.K. Schoolnik Inhibition of respiration by nitric oxide induces a Mycobacterium tuberculosis dormancy program J Exp Med 198 2003 705 713
19. T.R. Rustad, M.I. Harrell, R. Liao, and D.R. Sherman The enduring hypoxic response of Mycobacterium tuberculosis PLoS One 3 2008 e1502
20. D. Schnappinger, S. Ehrt, M.I. Voskuil, Y. Liu, J.A. Mangan, I.M. Monahan, G. Dolganov, B. Efron, P.D. Butcher, C. Nathan, and G.K. Schoolnik Transcriptional adaptation of Mycobacterium tuberculosis within macrophages: insights into the phagosomal environment J Exp Med 198 2003 693 704
21. P.C. Karakousis, T. Yoshimatsu, G. Lamichhane, S.C. Woolwine, E.L. Nuermberger, J. Grosset, and W.R. Bishai Dormancy phenotype displayed by extracellular Mycobacterium tuberculosis within artificial granulomas in mice J Exp Med 200 2004 647 657
22. D. Sharma, A. Bose, H. Shakila, T.K. Das, J.S. Tyagi, and V.D. Ramanathan Expression of mycobacterial cell division protein, FtsZ, and dormancy proteins, DevR and Acr, within lung granulomas throughout guinea pig infection FEMS Immunol Med Microbiol 48 2006 329 336
23. Y. Yuan, D.D. Crane, R.M. Simpson, Y.Q. Zhu, M.J. Hickey, D.R. Sherman, and C.E. Barry 3rd The 16-kDa alpha-crystallin (Acr) protein of Mycobacterium tuberculosis is required for growth in macrophages Proc Natl Acad Sci USA 95 1998 9578 9583
24. Y. Zhang Persistent and dormant tubercle bacilli and latent tuberculosis Front Biosci 9 2004 1136 1156
25. U.S. Gautam, K. Sikri, A. Vashist, V. Singh, and J.S. Tyagi Essentiality of DevR/DosR interaction with SigA for the dormancy survival program in Mycobacterium tuberculosis J Bacteriol 196 2014 790 799
26. A. Kumar, A. Lewin, P.S. Rani, I.A. Qureshi, S. Devi, M. Majid, E. Kamal, S. Marek, S.E. Hasnain, and N. Ahmed Dormancy associated translation inhibitor (DATIN/Rv0079) of Mycobacterium tuberculosis interacts with TLR2 and induces proinflammatory cytokine expression Cytokine 64 2013 258 264
27. R.L. Leistikow, R.A. Morton, I.L. Bartek, I. Frimpong, K. Wagner, and M.I. Voskuil The Mycobacterium tuberculosis DosR regulon assists in metabolic homeostasis and enables rapid recovery from nonrespiring dormancy J Bacteriol 192 2010 1662 1670
28. V. Malhotra, J.S. Tyagi, and J.E. Clark-Curtiss DevR-mediated adaptive response in Mycobacterium tuberculosis H37Ra: links to asparagine metabolism Tuberculosis (Edinb) 89 2009 169 174
29. K. Minch, T. Rustad, and D.R. Sherman Mycobacterium tuberculosis growth following aerobic expression of the DosR regulon PLoS One 7 2012 e35935
30. C. Boon, and T. Dick How Mycobacterium tuberculosis goes to sleep: the dormancy survival regulator DosR a decade later Future Microbiol 7 2012 513 518
31. D.J. Murphy, and J.R. Brown Identification of gene targets against dormant phase Mycobacterium tuberculosis infections BMC Infect Dis 7 2007 84
32. Y. Hong, X. Zhou, H. Fang, D. Yu, C. Li, and B. Sun Cyclic di-GMP mediates Mycobacterium tuberculosis dormancy and pathogenecity Tuberculosis (Edinb) 93 2013 625 634
33. V.L. Arcus, P.B. Rainey, and S.J. Turner The PIN-domain toxin-antitoxin array in mycobacteria Trends Microbiol 13 2005 360 365
34. O.I. Demidenok, A.S. Kaprelyants, and A.V. Goncharenko Toxin-antitoxin vapBC locus participates in formation of the dormant state in Mycobacterium smegmatis FEMS Microbiol Lett 352 2014 69 77
35. J.M. Schifano, and N.A. Woychik 23S rRNA as an a-Maz-ing new bacterial toxin target RNA Biol 11 2014 101 105
36. J.L. Flynn, and J. Chan Tuberculosis: latency and reactivation Infect Immun 69 2001 4195 4201
37. J.E. Rodríguez, A.S. Ramírez, L.P. Salas, C. Helguera-Repetto, J. Gonzalez-y-Merchand, C.Y. Soto, and R. Hernández-Pando Transcription of genes involved in sulfolipid and polyacyltrehalose biosynthesis of Mycobacterium tuberculosis in experimental latent tuberculosis infection PLoS One 8 2013 e58378
38. G. Mukamolova, E. Salina, and A. Kaprelyants Mechanisms of latent tuberculosis: dormancy and Resuscitation of Mycobacterium tuberculosis vol. 1 2008 National Institute of Allergy and Infectious Diseases, NIH 83 90 Frontiers in Research
39. M.O. Shleeva, E.G. Salina, and A.S. Kaprel'iants Dormant form of Mycobacterium tuberculosis Mikrobiologiia 79 2010 3 15
40. M.O. Shleeva, Y.K. Kudykina, G.N. Vostroknutova, N.E. Suzina, A.L. Mulyukin, and A.S. Kaprelyants Dormant ovoid cells of Mycobacterium tuberculosis are formed in response to gradual external acidification Tuberculosis (Edinb) 91 2011 146 154
41. E.G. Salina, H.J. Mollenkopf, S.H. Kaufmann, and A.S. Kaprelyants M. tuberculosis gene expression during transition to the "Non-Culturable" state Acta Naturae 1 2009 73 77
42. I. Keren, S. Minami, E. Rubin, and K. Lewis Characterization and transcriptome analysis of Mycobacterium tuberculosis persisters MBio 2 2011 e00100-11
43. S. Biketov, V. Potapov, E. Ganina, K. Downing, B.D. Kana, and A. Kaprelyants The role of resuscitation promoting factors in pathogenesis and reactivation of Mycobacterium tuberculosis during intra-peritoneal infection in mice BMC Infect Dis 7 2007 146
44. K.J. Downing, V.V. Mischenko, M.O. Shleeva, D.I. Young, M. Young, A.S. Kaprelyants, A.S. Apt, and V. Mizrahi Mutants of Mycobacterium tuberculosis lacking three of the five rpf-like genes are defective for growth in vivo and for resuscitation in vitro Infect Immun 73 2005 3038 3043
45. B.D. Kana, and V. Mizrahi Resuscitation promoting factors in bacterial population dynamics during TB infection Drug Discov Today Dis Mech 7 2010 e13-e8
46. A.K. Kesavan, M. Brooks, J. Tufariello, J. Chan, and Y.C. Manabe Tuberculosis genes expressed during persistence and reactivation in the resistant rabbit model Tuberculosis (Edinb) 89 2009 17 21
47. M. Cohen-Gonsaud, P. Barthe, C. Bagnéris, B. Henderson, J. Ward, C. Roumestand, and N.H. Keep The structure of a resuscitation-promoting factor domain from Mycobacterium tuberculosis shows homology to lysozymes Nat Struct Mol Biol 12 2005 270 273
48. M. Shleeva, A. Goncharenko, Y. Kudykina, D. Young, M. Young, and A. Kaprelyants Cyclic amp-dependent resuscitation of dormant mycobacteria by exogenous free fatty acids PLoS One 8 2013 e82914
49. J. Shendure The beginning of the end for microarrays? Nat Methods 5 2008 585 587
50. S. McGinn, and I.G. Gut DNA sequencing - spanning the generations N Biotechnol 30 2013 366 372
51. M.L. Metzker Sequencing technologies - the next generation Nat Rev Genet 11 2010 31 46
52. F. Ozsolak Third-generation sequencing techniques and applications to drug discovery Expert Opin Drug Discov 7 2012 231 243
53. K. Arnvig, and D. Young Non-coding RNA and its potential role in Mycobacterium tuberculosis pathogenesis RNA Biol 9 2012 427 436
54. K.B. Arnvig, I. Comas, N.R. Thomson, J. Houghton, H.I. Boshoff, N.J. Croucher, G. Rose, T.T. Perkins, J. Parkhill, G. Dougan, and D.B. Young Sequence-based analysis uncovers an abundance of non-coding RNA in the total transcriptome of Mycobacterium tuberculosis PLoS Pathog 7 2011 e1002342
55. K.B. Arnvig, and D.B. Young Identification of small RNAs in Mycobacterium tuberculosis Mol Microbiol 73 2009 397 408
56. P. Miotto, F. Forti, A. Ambrosi, D. Pellin, D.F. Veiga, G. Balazsi, M.L. Gennaro, C. Di Serio, D. Ghisotti, and D.M. Cirillo Genome-wide discovery of small RNAs in Mycobacterium tuberculosis PLoS One 7 2012 e51950
57. D. Pellin, P. Miotto, A. Ambrosi, D.M. Cirillo, and C. Di Serio A genome-wide identification analysis of small regulatory RNAs in Mycobacterium tuberculosis by RNA-Seq and conservation analysis PLoS One 7 2012 e32723
58. S. Uplekar, J. Rougemont, S.T. Cole, and C. Sala High-resolution transcriptome and genome-wide dynamics of RNA polymerase and NusA in Mycobacterium tuberculosis Nucleic Acids Res 41 2013 961 977
59. S. Mukhopadhyay, S. Nair, and S. Ghosh Pathogenesis in tuberculosis: transcriptomic approaches to unraveling virulence mechanisms and finding new drug targets FEMS Microbiol Rev 36 2012 463 485
60. T. Azhikina, T. Skvortsov, T. Radaeva, A. Mardanov, N. Ravin, A. Apt, and E. Sverdlov A new technique for obtaining whole pathogen transcriptomes from infected host tissues Biotechniques 48 2010 139 144
61. D. Ignatov, S. Malakho, K. Majorov, T. Skvortsov, A. Apt, and T. Azhikina RNA-seq analysis of Mycobacterium avium non-coding transcriptome PLoS One 8 2013 e74209
62. T.A. Skvortsov, D.V. Ignatov, K.B. Majorov, A.S. Apt, and T.L. Azhikina Mycobacterium tuberculosis transcriptome profiling in mice with genetically different susceptibility to tuberculosis Acta Naturae 5 2013 62 69
63. L.S. Waters, and G. Storz Regulatory RNAs in bacteria Cell 136 2009 615 628
64. R.A. Lease, D. Smith, K. McDonough, and M. Belfort The small noncoding DsrA RNA is an acid resistance regulator in Escherichia coli J Bacteriol 186 2004 6179 6185
65. A. Toledo-Arana, F. Repoila, and P. Cossart Small noncoding RNAs controlling pathogenesis Curr Opin Microbiol 10 2007 182 188
66. J.M. DiChiara, L.M. Contreras-Martinez, J. Livny, D. Smith, K.A. McDonough, and M. Belfort Multiple small RNAs identified in Mycobacterium bovis BCG are also expressed in Mycobacterium tuberculosis and Mycobacterium smegmatis Nucleic Acids Res 38 2010 4067 4078
67. S. Wang, X. Dong, Y. Zhu, C. Wang, G. Sun, T. Luo, W. Tian, H. Zheng, and Q. Gao Revealing of Mycobacterium marinum Transcriptome by RNA-seq PLoS One 8 2013 e75828
68. D.V. Ignatov, L.G. Mefodieva, K.B. Maiorov, T.A. Skvortsov, and T.L. Azhikina Novel small RNAs from Mycobacterium avium Russ J Bioorg Chem 38 2012 447 449
69. A.S. Apt Are mouse models of human mycobacterial diseases relevant? Genetics says: 'yes!' Immunology 134 2011 109 115
70. A.S. Apt, and T.K. Kondrat'eva Tuberculosis: pathogenesis, immune responses and genetics of the host Mol Biol Mosk 42 2008 880 890
71. D.G. Russell Who puts the tubercle in tuberculosis? Nat Rev Microbiol 5 2007 39 47
72. R.J. North, and Y.J. Jung Immunity to tuberculosis Annu Rev Immunol 22 2004 599 623
73. L.G. Wayne Dormancy of Mycobacterium tuberculosis and latency of disease Eur J Clin Microbiol Infect Dis 13 1994 908 914
74. E. Medina, and R.J. North Resistance ranking of some common inbred mouse strains to Mycobacterium tuberculosis and relationship to major histocompatibility complex haplotype and Nramp1 genotype Immunology 93 1998 270 274
75. E.R. Rhoades, A.A. Frank, and I.M. Orme Progression of chronic pulmonary tuberculosis in mice aerogenically infected with virulent Mycobacterium tuberculosis Tuber Lung Dis 78 1997 57 66
76. R.M. McCune, F.M. Feldmann, H.P. Lambert, and W. McDermott Microbial persistence. I. The capacity of tubercle bacilli to survive sterilization in mouse tissues J Exp Med 123 1966 445 468
77. R.M. McCune, F.M. Feldmann, and W. McDermott Microbial persistence. II. Characteristics of the sterile state of tubercle bacilli J Exp Med 123 1966 469 486
78. D. de Wit, M. Wootton, J. Dhillon, and D.A. Mitchison The bacterial DNA content of mouse organs in the Cornell model of dormant tuberculosis Tuber Lung Dis 76 1995 555 562
79. J. Dhillon, and D.A. Mitchison Effect of vaccines in a murine model of dormant tuberculosis Tuber Lung Dis 75 1994 61 64
80. C.A. Scanga, V.P. Mohan, H. Joseph, K. Yu, J. Chan, and J.L. Flynn Reactivation of latent tuberculosis: variations on the Cornell murine model Infect Immun 67 1999 4531 4538
81. E. Kondratieva, N. Logunova, K. Majorov, M. Averbakh, and A. Apt Host genetics in granuloma formation: human-like lung pathology in mice with reciprocal genetic susceptibility to M. tuberculosis and M. avium PLoS One 5 2010 e10515
82. E. Schurr, and I. Kramnik Genetic control of host susceptibility to tuberculosis S. Kaufmann, W. Britten, Handbook of tuberculosis 2008 Wiley-VCH Weinheim, Germany
83. H.F. Lecoeur, P.H. Lagrange, C. Truffot-Pernot, M. Gheorghiu, and J. Grosset Relapses after stopping chemotherapy for experimental tuberculosis in genetically resistant and susceptible strains of mice Clin Exp Immunol 76 1989 458 462
84. T.V. Radaeva, B.V. Nikonenko, V.V. Mischenko, M.M. Averbakh Jr., and A.S. Apt Direct comparison of low-dose and Cornell-like models of chronic and reactivation tuberculosis in genetically susceptible I/St and resistant B6 mice Tuberculosis (Edinb) 85 2005 65 72
85. T.V. Radaeva, E.V. Kondratieva, V.V. Sosunov, K.B. Majorov, and A. Apt A human-like TB in genetically susceptible mice followed by the true dormancy in a Cornell-like model Tuberculosis (Edinb) 88 2008 576 585
86. D.G. Russell Mycobacterium tuberculosis and the intimate discourse of a chronic infection Immunol Rev 240 2011 252 268
87. T. Kondratieva, E. Rubakova, B.D. Kana, S. Biketov, V. Potapov, A. Kaprelyants, and A. Apt Mycobacterium tuberculosis attenuated by multiple deletions of rpf genes effectively protects mice against TB infection Tuberculosis (Edinb) 91 2011 219 223
88. M. Ibrahim, C. Truffot-Pernot, K. Andries, V. Jarlier, and N. Veziris Sterilizing activity of R207910 (TMC207)-containing regimens in the murine model of tuberculosis Am J Respir Crit Care Med 180 2009 553 557
89. E. Nuermberger, I. Rosenthal, S. Tyagi, K.N. Williams, D. Almeida, C.A. Peloquin, W.R. Bishai, and J.H. Grosset Combination chemotherapy with the nitroimidazopyran PA-824 and first-line drugs in a murine model of tuberculosis Antimicrob Agents Chemother 50 2006 2621 2625
90. B.V. Nikonenko, and A.S. Apt Drug testing in mouse models of tuberculosis and nontuberculous mycobacterial infections Tuberculosis (Edinb) 93 2013 285 290
91. E.R. Driver, G.J. Ryan, D.R. Hoff, S.M. Irwin, R.J. Basaraba, I. Kramnik, and A.J. Lenaerts Evaluation of a mouse model of necrotic granuloma formation using C3HeB/FeJ mice for testing of drugs against Mycobacterium tuberculosis Antimicrob Agents Chemother 56 2012 3181 3195
92. R. Tasneen, S. Tyagi, K. Williams, J. Grosset, and E. Nuermberger Enhanced bactericidal activity of rifampin and/or pyrazinamide when combined with PA-824 in a murine model of tuberculosis Antimicrob Agents Chemother 52 2008 3664 3668
93. S. Buccheri, R. Reljic, N. Caccamo, S. Meraviglia, J. Ivanyi, A. Salerno, and F. Dieli Prevention of the post-chemotherapy relapse of tuberculous infection by combined immunotherapy Tuberculosis (Edinb) 89 2009 91 94
94. K.A. Sacksteder, M. Protopopova, C.E. Barry 3rd, K. Andries, and C.A. Nacy Discovery and development of SQ109: a new antitubercular drug with a novel mechanism of action Future Microbiol 7 2012 823 837
95. K. Williams, A. Minkowski, O. Amoabeng, C.A. Peloquin, D. Taylor, K. Andries, R.S. Wallis, K.E. Mdluli, and E.L. Nuermberger Sterilizing activities of novel combinations lacking first- and second-line drugs in a murine model of tuberculosis Antimicrob Agents Chemother 56 2012 3114 3120